Ajay Nooka, MD MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen Pharmacaeuticals
    Date added:
    09/09/2023
    Date updated:
    09/09/2023
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Date added:
    09/09/2023
    Date updated:
    09/09/2023
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sanofi
    Date added:
    09/09/2023
    Date updated:
    09/09/2023
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Date added:
    09/09/2023
    Date updated:
    09/09/2023
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Adaptive biotechnology
    Date added:
    09/09/2023
    Date updated:
    09/09/2023
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Date added:
    09/09/2023
    Date updated:
    09/09/2023
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Cellectar
    Date added:
    09/09/2023
    Date updated:
    09/09/2023
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GSK
    Date added:
    09/09/2023
    Date updated:
    09/09/2023
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    ONK therapeutics
    Date added:
    09/09/2023
    Date updated:
    09/09/2023
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    K36 therapeutics
    Date added:
    09/09/2023
    Date updated:
    09/09/2023
    Relationship end date:
    12/31/2024
Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice